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ABSTRACT 
Objective: The present study was undertaken to investigate the antidiabetic potential of the leaves of Ipomoea batatas.  
Methods: The crude powder, 95% ethanolic, 50% ethanolic and aqueous extracts of Ipomoea batatas leaves were administered to normoglycemic 
and streptozotocin (STZ)-induced diabetic rats in a single dose study. The chloroform, butanol and aqueous fractions of aqueous extract were 
investigated for their antihyperglycemic on STZ-induced diabetic rats. Multiple dose study of an aqueous fraction was also done in STZ and neonatal 
STZ-induced diabetic rats. Further, the aqueous fraction was measured against the alpha glucosidase and aldose reductase enzymes, and glucose 
uptake in L6 myotubes. 
Results: The aqueous extract showed significant lowering of postprandial hyperglycemia of post sucrose loaded normal rats and significantly 
declined the blood glucose level of STZ-induced diabetic rats. The aqueous fraction at a single dose of 100 mg/kg b. w in comparison with 
chloroform and butanol fractions significantly lowered the blood glucose level of STZ-induced diabetic rats. The aqueous fraction in a multiple dose 
study were found to significantly improved the percent glycated hemoglobin (%HbA1c), fasting blood glucose, oral glucose tolerance (OGTT), serum 
insulin, lipid profile, liver and kidney parameters in STZ-induced diabetic rats. Marked improvement in OGTT and serum insulin levels was also 
found in neonatal STZ-induced diabetic rats. In vitro study, the aqueous fraction of I. batatas increased glucose uptake in L6 myotubes and inhibits 
the α-glucosidase and aldose reductase enzymes.  
Conclusion: The present study demonstrated the significant antidiabetic activity of the I. batatas leaves by promoting insulin secretion, alpha 
glucosidase and aldose reductase enzyme inhibition. 
Keywords: Antidiabetic activity, Antidyslipidemic activity, Glucose uptake, STZ-induced rats, Neonatal STZ induced diabetic rats, Ipomoea batatas leaves.  
 
INTRODUCTION 
Diabetes mellitus (DM) is a heterogeneous group of metabolic 
disorders characterized by chronic hyperglycemia i.e. persistent 
high blood glucose level. The chronic hyperglycemia in diabetes is 
associated with long-term damage, dysfunction, and failure of 
different organs, mainly the eyes, kidneys, heart and blood vessels 
[1]. Although currently available oral antidiabetic agents have a 
number of serious adverse effects; thus, managing diabetes without 
any side effects is still a challenge. Hence, the search for more safer, 
specific and valuable hypoglycemic agents has constantly been an 
area of important investigation. The plants exhibiting blood glucose 
lowering effect have been listed in the available literature; though 
partial mechanism (s) of their mode of action is available for only 
about one-fourth of them. However, in the traditional system the 
herbal drugs with antidiabetic effect have been acclaimed and 
accepted for their therapeutic purposes, still they are yet to get 
commercially formulated just like modern drugs. The easily 
available traditional plants provide prospective for finding 
antidiabetic drugs. Therefore, the present study was conducted to 
identify the antidiabetic potential of leaves of Ipomoea batatas. 
Ipomoea batatas L. (Family: Convolvulaceae) is commonly known as 
sweet potato, it is the world’s sixth largest food crop, which is widely 
grown in tropical, subtropical and warm temperate regions [2]. It is 
an important food crop in many countries, also cultivated for its use 
as animal feed and as a medicinal plant [3]. In the region of Kagawa, 
Japan, a variety of white sweet potato has been eaten raw to treating 
anemia, hypertension and diabetes [4]. A study in rats has shown 
that I. batatas leave are a good source of polyphenols, antioxidants 
and possess vascular relaxing properties [5]. The anti hyperglycemic 
and antidiabetic activities have been reported for I. batatas tuber 
roots in STZ-induced type 2 diabetes model rats and obese Zucker 
rats [6-9]. It has been shown by Li et al., in 2009 that the flavonoids 
from I. batatas leaf exerts both antihyperglycemic and 
antidyslipidemic activities in alloxan-induced diabetic mice [10]. It 
has been also tested clinically that when patients with type 2 
diabetes were given I. batatas treatment given for 3 months, 
resulted in lowering of plasma glucose and cholesterol levels in 
patients [4,11]. Therefore, the present study was focused on 
investigating the antidiabetic activity of crude extracts and role of an 
aqueous fraction of active aqueous extracts of I. batatas leaves in 
validated diabetic animal models. 
MATERIALS AND METHODS  
Chemicals 
Streptozotocin, metformin, glybenclamide, Dulbeco Minimum 
Essential Medium (DMEM), fetal bovine serum, pencillin G, 
antibiotics, trypsin, insulin and other chemicals are from Sigma-
Aldrich Chemical Company (St. Louis, MO (USA). All other reagents 
used were of the highest purity grade. 2-Deoxy-D-[3H]-glucose (2-
DG) was procured from Perkin Elmer, USA. Sucrose, glucose, 
fructose, and cholesterol, scintillation cocktail were purchased from 
Sisco Research Laboratories, Mumbai (India). The serum 
triglycerides and total cholesterol were measured using Dialab 
diagnostic kits. The blood glucose level was measured using glucose 
strips which were obtained from Roche (India). 
Animals  
Male albino rats of Sprague Dawley (SD) Strain (140-180 g) of 8-10 
weeks of age and male neonatal rats (weighing 7±2 gm) of 2 days 
were obtained from the animal colony of CSIR-Central Drug 
Research Institute, Lucknow. The animals were always housed in 
polypropylene cages in groups of 3 to 6. All the animals were kept in 
the animal room under standard conditions (23±2 °C, 50%-60% 
relative humidity, light and dark cycles of 12 h each). The animals 
were provided pellet diet and tap water ad libitum unless stated 
otherwise. As per the guidelines of the Committee for the Purpose of 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 7, Issue 7, 2015 
Innovare 
Academic Sciences 
Srivastava et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 7, 176-186 
177 
Control and Supervision of Experiments on Animals (CPCSEA) formed 
in the year 1964 by the Indian government, suitable permission was 
acquired from CSIR-CDRI institutional animal ethics committee (Ethics 
Committee Approval Reference No. IAEC/2008/63/Renewal 04 dated 
16.05.2012) for animal experiments. 
Collection of plant material and preparation of extracts and 
fractions of I. batatas leaves 
Leaves of I. batatas were purchased from the local market and its 
identity was authenticated in the laboratory of CDRI. The shade dried 
material was cut into fine pieces and powdered by a mechanical grinder, 
passed through 100 mesh sieve and the powder was stored in airtight 
containers until used. The powdered leaves (3.0 kg) of I. batatas were 
percolated in 10 volumes of 95 % ethyl alcohol five times successively. 
The combined extract was filtered and concentrated under high vacuum 
in a rotavapour and termed ethanolic extract. In the same manner the 
crude powder was extracted with ethanol: water (50:50) and distilled 
water, respectively.  
The collective 50% ethanol and aqueous extracts were separated out 
and were further concentrated under reduced pressure at 45ºC 
using rotavapour and termed as 50% ethanolic (ethanol: aqueous) 
and aqueous extracts. Ethanolic, 50% ethanolic, aqueous extracts 
were stored at − 20º
Induction of diabetes 
C until used. The crude aqueous extract was 
macerated with n-hexane; the insoluble residue was macerated with 
chloroform to give chloroform soluble fraction and an insoluble 
residue. The chloroform insoluble residue was portioned between n-
butanol and water to give n-butanol soluble fraction and water 
soluble fractions, these entire fractions were then concentrated 
under reduced pressure on rotatory evaporator at 50 °C and finally 
dried under vacuum to get final fractions for evaluation of 
antidiabetic activity. 
To the 16 h overnight fasted animals, streptozotocin freshly 
prepared in citrate buffer (0.1 M, pH 4.5) at a dose of 60 mg/kg was 
orally administered intraperitoneally (i. p.) for induction of diabetes. 
Diabetes rats were characterized by identification of features 
specific for diabetes, such as polydipsia, polyuria and increased 
fasting blood glucose levels 72 h observed in STZ treated rats. Rats 
with blood glucose levels above 280-450 mg/dl after were selected 
for experiments. 
Single dose effect 
Oral glucose tolerance test of normal rats 
Male albino rats of Sprague Dawley (SD) (140-180 g) were selected 
and kept on an overnight starvation. Next morning the blood glucose 
level (0 min) of each animal was measured by glucometer using 
glucostrips. Animals showing their fasting blood glucose levels 
between 60 to 80 mg/dl (3.33-4.44 mM) were finally selected and 
divided into groups, consisting six animals in each group. Each rat of 
experimental groups was given suspension of the test substances 
made in 1.0% gum acacia at desired dose levels, i.e. 250 mg/kg b.w. 
in the case of crude/extracts and 25 mg/kg in the case of standard 
antidiabetic drug i.e. glybenclamide. An equal amount of 1.0% gum 
acacia (vehicle) was given to each rat of control group animals, and 
termed as sham treated control. An oral sucrose load (10 gm/kg b. 
w) was given to each animal exactly 30 min post administration of 
the test sample/standard drug/vehicle and the blood glucose level 
was measured at 0, 30, 60, 90 and 120 min post sucrose load. During 
the course of the experimentation food was withheld, but water was 
provided to the animals in the cages. Comparing the AUC of the 
experimental vs. control group determined the % lowering of blood 
glucose [12]. 
Effect of crude powder and extracts/fractions of leaves of I. 
batatas on blood glucose of streptozotocin-induced diabetic rats 
Streptozotocin induced diabetic rats with marked elevation in 
fasting blood glucose levels above 280-450 mg/dl were used for this 
study. The selected diabetic rats were randomly divided into groups 
consisting of six animals in each group. The plant crude powder and 
its extracts, fractions and standard antidiabetic drug, metformin 
were prepared as suspensions made in 1.0% gum acacia and were 
orally administered at a pre selected dose of 250 mg/kg for crude 
powder/extracts and 100 mg/kg b.w. dose for fractions and 
metformin. At post administration of the test sample/ 
vehicle/standard drug the blood glucose level of each animal was 
measured by glucostrips at 0, 30, 60, 90, 120, 180, 240, 300, and at 
1440 min [13]. During 0 to 300 min of experimentation food was 
withheld, but water was provided to the animals in the cages. The 
percentage lowering of blood glucose levels by test samples or 
standard drug was determined by plotting the mean blood glucose 
levels against time and calculating the area under the curve (AUC) 
between 0-300 min and 0-1440 min.  
Multiple dose effect  
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
on streptozotocin-induced diabetic rat model 
Streptozotocin induced diabetic rats with marked elevation in 
fasting blood glucose levels above 280-450 mg/dl were used for this 
study. These STZ-induced diabetic rats were left untreated for a 
period of 10 weeks to develop secondary complications in 
association with the chronic diabetes. The diabetic animals which 
showed percent glycated haemoglobin more than 8 were selected 
for this study and grouped into three with six animals in each group. 
The group, which served as a diabetic control was administered with 
1.0 % gum acacia as a vehicle, whereas, the second and third groups 
were given an aqueous fraction of aqueous extract of I. batatas 
leaves and metformin at the desire dose levels of (100 mg/kg) for a 
period of 30 days. The fasting blood glucose level and OGTT post 
glucose loads of each rat were examined at the time of start and on 
day 7, 14, 21, and 28.  
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
on Neonatally-streptozotocin treated diabetic rats 
Two-day-old pups of Sprague Dawley strain (weighing 7±2 gm), 
were injected 90 mg/kg STZ prepared in citrate buffer 0.1 M, pH 4.5 
and left along with their mothers for 4 weeks. The rats separated 
from the mothers were further kept for 3 months in polypropylene 
cages and given a pellet diet and water ad libitum. These animals 
showed signs of polydypsia, polyurea and abnormal OGTT at the end 
of the period. These rats were randomly divided into three groups of 
five animals. Group I (diabetic control group) received 1% gum 
acacia, Group II (experimental group) received test sample i.e. 
aqueous fraction of leaves of I. batatas at 100 mg/kg body weight 
dose and Group III (standard group) received standard drug, 
metformin at 100 mg/kg body weight dose. Fasting blood glucose, 
serum insulin and OGTT post glucose loads of these animals were 
followed at weekly intervals for 30 days [14]. 
Oral glucose tolerance test  
For the oral glucose tolerance test, 3.0 gm/kg post glucose load 
glucose was administered to rats that had been fasted for 16 h. 
Blood samples were collected from a tail vein and blood glucose was 
measured at 0, 30, 60, 90 and 120 min. Effect on oral glucose 
tolerance was obtained by calculating the area under the curve for 
the values of blood glucose between 0-120 min.  
Blood biochemical parameters  
On day 10, 20, and 30, the blood was withdrawn from the retro-
orbital plexus of each rat for the estimation of the triglycerides, 
cholesterol, LDL-C and HDL-C, ALT, AST, urea, uric acid, creatinine 
and %HbA1c levels were measured on semi-auto-analyzer (Dialab) 
using the assay kits and instructions from the manufacturer. The 
serum insulin content was determined using the rat Insulin enzyme-
linked immunosorbent assay (ELISA) kit (Mercodia, Uppsala, 
Sweden). 
Cell culture 
L6 rat skeletal muscle cell lines, procured from the National Center 
of Cell Sciences (NCCS), Pune, India were cultured in DMEM 
supplemented with 10% FBS, penicillin (100 units/ml), 
streptomycin (200 μg/ml) and gentamycin (50 μg/ml) in a 
humidified atmosphere of 5% CO2 and 95% air at 37 °C 26, 27. 
Differentiation was induced by switching confluent cells to medium 
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supplemented with 2% FBS. Experiments were performed in 
differentiated myotubes 4-6 days after seeding. The cells were 
maintained for another five to seven days and media were changed 
every 48h prior to use in experiments. 
Glucose uptake assay  
Glucose uptake was performed as previously described by 
Srivastava et al., 2014 [13]. In brief, differentiated L6 myotubes 
grown in 24-well plate (6×104 cells/well) were incubated with 
different concentrations of the aqueous fraction of leaves of I. 
batatas or standard drug, metformin at a 500μM concentration for 
16 h with final 3 h in serum-deprived medium and a sub-set of cells 
were given stimulation with insulin at 100 nM concentration for 20 
min. Glucose uptake was assessed for 5 min in HEPES-buffered 
saline (pH 7.4)] containing 10 μM 2-DG (0.5 μCi/ml 2-[3H] DG) at 
room temperature. After the uptake period, radioactive solution was 
rapidly aspired, and the cell mono layers were rinsed with an ice-
cold HEPES buffered containing 0.9% NaCl and 25 mM D-glucose. 
The radioactivity associated with cell was quantified, by cell lysis 
and lysates were counted with scintillation fluid in β-counter 
(Beckman Coulter, USA). The assays were performed in triplicates 
and normalized to total protein, was expressed as fold change with 
respect to control.  
In-vitro enzyme inhibition assays 
α-Glucosidase assay  
α-Glucosidase enzyme inhibition assay was performed according to 
a slight modification of the procedure reported by Pistia-
Brueggeman and Hollingsworth, 2001 [15]. 100 µl of the purified µ-
glucosidase (0.1 mg/ml) was added to the assay system containing 
500 µl of 67 mM phosphate buffer (pH 6.8), 100 µl of glutathione 
(1.0 mg/ml) and the desired concentrations of the test sample or 
standard inhibitor acarbose and the final volume was made to 1000 
µl. The reaction was started by the addition of 100 µl p-nitrophenyl-
α-D-glucopyranoside (1.0 M) and terminated by the addition of 500 
μl of 0.1 M sodium carbonate. The IC50
The lens homogenate was prepared according to the protocol as 
previously described [16]. The lenses from both the normal as well 
as STZ-induced diabetic rats, after cervical dislocation, were 
immediately enucleated and washed with saline, and their fresh 
weight was recorded. 40 eye lenses of each were pooled and 10% 
lens homogenate was prepared in 0.1 M phosphate buffer saline (pH 
7.4) by using Potter Elvejhem glass homogenizer with Teflon pestle, 
the prepared homogenate was separated out by muslin cloth and the 
filtrate was centrifuged at 5000×g for 15 min at 4 °C, further the 
supernatant was collected and used as an enzyme source in 
applications, and kept at-70 °C for storage until used. Protein 
content in the supernatant of the lens homogenate was estimated 
according to Lowry et al., (1951) method [17].  
 value was defined as the 
concentration of α-glucosidase inhibitor to inhibit 50% of its activity 
under the assay conditions. The absorbance of colored p-
nitrophenol liberated was read on 410 nm. One unit of enzyme 
activity is 1.0 μmol p-nitrophenol formed per min per mg protein. 
Aldose reductase (AR) assay 
The method of Hayman and Kinoshita (1965) was used to measure 
AR activity of Lens. In brief, the decrease in the absorption of NADPH 
at 340 nm over a 3-min period was measured by using 
DL±Glyceraldehyde as a substrate [18]. The aldose reductase 
inhibition was determined as follows: 0.7 ml of 67 mM sodium 
phosphate buffer of pH 6.2, 0.1 ml of NADPH (25 × 10-5 M), 0.1 ml of 
DL±Glyceraldehyde (substrate, 1 × 10−3
The enzymatic reaction starts with the addition of the substrate into 
the solution mixture and the absorbance in optical density (O. D) 
was recorded at 340 nm for 3 min at 30s intervals. The aldose 
reductase inhibitory activity was calculated and expressed as ΔO. 
D./min/mg protein. The percentage inhibition (%) was calculated as 
[(ΔO. D. Sample/min)/(ΔO. D. Control/min) X100-100], where ΔO. D. 
Sample/min depicts the decrease in absorbance for 3 min with test 
sample and ΔO. D. Control/min represents the same, but with 1% 
DMSO instead of samples. 
Statistical analysis 
Each parameter was expressed as mean±S. E. Statistical 
comparisons between groups were made by Dunnett’s test. The 
results were considered significant if p values are 0.5 or less. 
RESULTS 
Effect of crude powder and extracts of I. batatas leaves on post-
sucrose loaded normal rats 
 M) and 0.1 ml of lens 
supernatant to a final volume of 1 ml were mixed in the sample 
cuvette and read against a reference cuvette containing all 
components except the substrate, DL±Glyceraldehyde. The pH of the 
reaction mixture was finally adjusted at pH-6.2.  
Table 1 and fig. 1A represent the effect of crude powder, ethanolic, 
ethanolic: aqueous and aqueous extracts and standard drug, 
glybenclamide on percent improvement of glucose tolerance on 
post-sucrose loaded normal. It is evident from the results that the 
crude powder of I. batatas leaves showed average percent 
improvement of glucose tolerance around 14.0%, while among all 
the extracts, the aqueous extract of I. batatas leaves showed the 
most significant improvement (18.4%, p<0.01) on oral glucose 
tolerance of post sucrose loaded normal rats. The standard drug, 
glybenclamide caused significant improvement around by 30.4% 
(p<0.01) of inhibition on the rise of post-prandial hyperglycemia of 
sucrose loaded normal rats at 25 mg/kg dose. 
 
Table 1: Effect of crude powder and ethanolic, ethanolic: aqueous and aqueous extracts of I. batatas leaves and standard antidiabetic 
drugs on the improvement of glucose tolerance post sucrose load in normal rats and blood glucose lowering on STZ-induced diabetic rats 
Treatment  Dose 
(mg/kg) 
Blood glucose level (AUC±SEM) 
Sucrose loaded normal rats 
(OGTT) 
STZ-induced diabetic rats 
(0-120 min) 0-300 min 0-1440 min 
Sham treated Control (1.0% Gum acacia) - 15160±257.3 118000±2940 610000±16080 
Crude powder  250 12950±279.9 (14.0%) 87300±706 (26.0%)** ns 473000±23240 (22.6%)** 
Ethanolic extract  250 12700±122.3 (16.2%)** 101000±2060 (14.4%)* 544400±15950 (10.8%)
Ethanolic: aqueous extract  
ns 
250 13070±355.8 (13.8%) 107000±4000 (9.32%)ns 539200±14230 (11.6%)ns 
Aqueous extract  
ns 
250 12280±90.63 (18.4%)** 93400±848 (20.8%)** 504200±10450 (17.3%)* 
Glybenclamide  25 10550±77.8 (30.4%)** - - 
Metformin  100 - 83900±1220 (28.9%)** 426000±8845 (30.2%)** 
 Values are mean±SE of six rats, p*<0.05, p**<0.01,ns: not significant 
 
Effect of crude powder and extracts of I. batatas leaves on blood 
glucose levels of STZ-induced diabetic rats  
Table 1 presents the blood glucose profile of the STZ-induced 
diabetic rats treated with crude powder, ethanolic, ethanolic: 
aqueous, aqueous extracts of I. batatas leaves and the standard 
antidiabetic drug, metformin. Of these, crude powder and its 
aqueous extract showed significant decline in fasting blood glucose 
level at the selected doses of 250 mg/kg b. w on STZ-induced 
diabetic rats. The average antihyperglycemic activity of the crude 
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powder and its aqueous extract was calculated to be around 26.0% 
and 20.8 % during the period 0-300 min, respectively, and 22.6% 
and 17.3 % during the period 0-1440 min, respectively. Whereas, 
the standard drug, metformin caused blood glucose lowering effect 
on STZ-treated diabetic rats at 100 mg/kg b. w dose. The average 
antihyperglycemic activity of metformin was estimated to be around 
28.9% and 30.2 % during the period 0-300 min and 0-1440 min, 
respectively (fig. 1B and 1C). 
 
 
Fig. 1: Effect of crude powder and ethanolic, ethanolic: aqueous and aqueous extracts of I. batatas leaves and standard antidiabetic drugs 
(A) on post sucrose loaded normal, during 0-120 min and on STZ-induced diabetic rats (B) during 0-300 min (C) during 0-1440 min 
 
Effect of fractions of aqueous extract of I. batatas leaves on 
blood glucose levels of STZ induced diabetic rats 
Table 2 represents the antihyperglycemic effect of the fractions i.e. 
aqueous, butanol and chloroform of aqueous extract of I. batatas 
leaves and the standard antidiabetic drug, metformin, on fasting 
blood glucose level of STZ-induced diabetic rats. The corresponding 
blood glucose lowering were calculated to be around 17.6%, 1.43% 
and 12.5%, during 0-300 min and around 15.0%, 8.93% and 14.7%, 
during 0–1440 min, at post treatment, respectively for each 
aqueous, butanol and chloroform fractions. The standard 
antidiabetic drug metformin caused lowering in fasting blood 
glucose levels of STZ-induced diabetic to the tune of 31.2% (p<0.01) 
and 24.8% (p<0.01) during 0-300 min and 0–1440 min, respectively. 
 It is evident from the results that aqueous fraction showed most 
significant decline in fasting blood glucose level of STZ-induced 
diabetic rats at the dosage of 100 mg/kg of body weight. The effect 
was started from 60 min which persisted till the end of the 
experiment i.e. 1440 min as shown in fig. 2. 
 
Table 2: Effect of fractions of aqueous extract of I. batatas leaves and standard antidiabetic drug, metformin on blood glucose levels of STZ 
induced diabetic rats 
Treatment  Dose (mg/kg)  Blood glucose lowering (STZ rats) (AUC±SEM) 
0-300 min 0-1440 min 
Sham treated control (1.0% Gum acacia) - 125900±3354 632600±16440 
Chloroform fraction  100 110200±4517 (12.5%) 539500±19180 (14.7%)* ns 
Butanol fraction  100 124100±8891 (1.43%) 576100±11420 (8.93%)ns 
Aqueous fraction  
ns 
100 103700±3148 (17.6%)** 537600±34780 (15.0%)** 
Metformin treated 100 86620±2282 (31.2%)** 475800±19160 (24.8%)** 
Values are mean±S. E. of six rats. p*<0.05, p**<0.01, ns: not significant  
 
 
Fig. 2: Effect of fractions I. batatas leaves and standard 
antidiabetic drug, metformin on blood glucose levels of STZ 
induced diabetic rats 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
on fasting blood glucose and glucose tolerance (OGTT) of STZ-
induced diabetic rats 
Table 3 depicts the effect of an aqueous fraction of aqueous extract 
of I. batatas leaves and metformin on fasting blood glucose and 
oral glucose tolerance (OGTT) of STZ-induced diabetic rats. It is 
evident from the table 3 that an aqueous fraction of I. batatas 
leaves when given to STZ-induced diabetic rats at 100 mg/kg p. o. 
for 30 consecutive days declined their fasting blood glucose level 
and improved OGTT as compared to the sham treated control 
group. The decline in the fasting blood glucose was calculated to 
be around 17.8 % (p<0.01) and 28.0% (p<0.01), whereas an 
improvement on OGTT, was around 13.5% (p<0.05), and 24.7% 
(p<0.01 on day 14 and 28, respectively in aqueous fraction of I. 
batatas leaves treated group. While the metformin treated group 
showed a decline in fasting blood glucose and an improvement on 
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OGTT were calculated to be around 20.6 % (p<0.01) and 29.7% 
(p<0.01) and 17.2% (p<0.01) and 30.6% (p<0.01) on day 14 and 
28, respectively at the dose of 100 mg/kg p. o. when compared to 
the sham treated control group (fig. 3A and fig. 3B). 
 
 
Fig. 3: Effect of aqueous (aqu) fraction of I. batatas (I. b) Leaves on glucose tolerance (OGTT) of streptozotocin induced diabetic rats (A) on 
day 14, and (B) on day 28 
 
Table 3: Effect of an aqueous fraction of I. batatas leaves and standard drug metformin on fasting blood glucose and improvement in 
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Values are mean±SE. of six rats. p*<0.05, p**<0.01, ns: not significant   
 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
and standard drug metformin on body weight and %HbA1C
Table 4 depicts the effect of an aqueous fraction of I. batatas leaves 
and standard drug, metformin, on body weight and percentage (%) 
HbA1c of STZ induced diabetic rats after 30 days of treatmentat the 
doses of 100 mg/kg, respectively. The aqueous fraction of I. batatas 
leaves treatment when given at 100 mg/kg post oral (p. o.) for 30 
consecutive days to STZ induced diabetic rats showed no significant 
improvement in body weight, while metformin treated group 
showed significant (19.2%, p<0.01) restoration of the body weight 
on day 30 at the dose of 100 mg/kg (fig. 4A).  
 of 
STZ-induced diabetic rats 
The % HbA1c level of aqueous fraction of I. batatas leaves treated group 
on day 30 at the dose of 100 mg/kg was suppressed 40.2% (p<0.01), as 
compared to diabetic control group and in metformin treated group % 
HbA1c level observed was around 52.1% (p<0.01) (fig. 4B). 
Effect of aqueous fraction of aqueous extract of I. batatas leaves on 
serum insulin level and lipid profile of STZ-induced diabetic rats 
Table 5 presents effect of aqueous fraction of aqueous extract of I. 
batatas leaves and metformin treatment at the doses of 100 mg/kg 
b. w on the serum insulin level and lipid profile of STZ-induced 
diabetic rats. The aqueous fraction of leaves of I. batatas and 
metformin treated groups showed significant increased in serum 
insulin level compared to sham treated control group on day 10 and 
30, respectively. Table 5 also shows the effect of an aqueous fraction 
of I. batatas on the serum lipid profile of STZ-induced diabetic rats. 
The aqueous fraction of leaves of I. batatas caused 10.8% and 29.9% 
decline in serum triglycerides, around 9.42% and 34.3% decline in 
serum cholesterol level and 11.7 and 33.5% decline in serum LDL-
cholesterol levels of STZ rats on day 10 and 30, respectively. The 
aqueous fraction of leaves of I. batatas caused a rise in HDL-
cholesterol level to around 6.52% and 12.6% on day 10 and 30, 
respectively. The standard drug, metformin, when given at the 
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dosage of 100 mg/kg body weight (b. w) for 30 successive days did 
not significantly either lowers the serum triglycerides, cholesterol 
and LDL-cholesterol levels nor raised the level of serum HDL-
cholesterol of streptozotocin-induced diabetic rats. 
 
Table 4: Effect of aqueous fraction of I. batatas leaves and standard drug metformin on body weight and %HbA1c of STZ-induced diabetic rats 
Group Dose (mg/kg) Body Weight (gm) % HbA1c  
Initial (0 day) Final (30 day) Initial (0 day) Final (30 day) 
Normal Control  
(1.0% Gum acacia) 
- 182.7±2.67 196.0±3.99 4.87±0.599 4.90±0.33 
Sham treated control (1.0% Gum acacia)  - 152.6±3.46 139.8±5.03 11.9±0.84 12.4±0.92 






 7.41±0.60 (40.2%)** 
Metformin treated 
 





Values are mean±SE of six rats. p*<0.05, p**<0.01, ns: not significant 
 
 
Fig. 4: Effect of aqueous fraction (frac) of leaves of I. batatas and standard drug, metformin, on (A) Body weight and (B) %HbA1c of STZ-
induced diabetic rats. Values are mean±SEM of six rats. Statistical significance *p<.01, **p<0.001 compared to sham control 
 
Table 5: Effect of aqueous fraction of I. batatas leaves and standard drug metformin on serum insulin level and lipid profile of STZ-
induced diabetic rats 
Group Day Insulin ((µg/l) Biochemical profiles (Serum) 
TG (mg/dl) TC (mg/dl) LDL-C mg/dl) HDL-C (mg/dl) 
Sham treated Normal Control (1.0% Gum 
cacia) 
0 0.174±0.006 62.3±13.0 84.3±2.41 30.0±2.93 39.8±2.64 
10 0.167±0.007 64.0±3.06 86.7±2.46 31.5±0.76 39.7±3.93 
20 0.163±0.009 64.5±5.24 89.0±1.90 32.2±0.60 39.3±0.76 
30 0.164±0.018 65.8±2.41 89.2±1.85 33.3±0.49 40.3±2.90 
Sham treated Diabetic Control (1.0% Gum 
cacia) 
0 0.084±0.001 134.7±3.12 116.3±2.35 65.7±5.09 23.7±1.66 
10 0.082±0.001 136.0±2.58 117.8±2.00 65.6±0.80 23.0±0.80 
20 0.082±0.003 137.5±1.61 120.8±0.99 67.2±1.01 22.8±1.60 
30 0.081±0.003 139.0±1.44 122.3±1.33 68.0±2.17 22.5±1.86 
Aqueous fraction of aqueous extract of I. 
batatas leaves treated (100 mg/kg p. o) 
0 0.087±0.001 135.2±3.50 114.8±2.18 66.2±7.18 22.5±1.77 






























(100 mg/kg p. o) 
0 0.085±0.001 134.7±4.02 117.8±3.61 69.2±8.46 25.7±2.39 




























Values are mean±SE. of six rats. p*<0.05, p**<0.01, ns: not significant 
 
Effect of aqueous fraction of aqueous extract of I. batatas leaves on 
liver and kidney function parameters of STZ-induced diabetic rats 
Table 6 depicts the effects of aqueous fraction of aqueous extract of 
I. batatas leaves and metformin on liver and kidney function 
markers of STZ-induced diabetic rats. The aqueous fraction of leaves 
of I. batatas caused 8.75 and 35.4 % decline in serum ALT activity 
and around 7.67 and 21.3 % decline in serum AST activity on day10 
and 30, respectively. In comparison metformin caused 11.4 % and 
33.8% decline in ALT activity, 8.99 and 23.7% decline in AST activity 
on day 10 and 30, respectively. The kidney functions were also 
improved in the aqueous fraction of I. batatas treated group as 
nearly 5.99 and 18.9 % decline in serum urea levels on day10 and 
30, respectively, 13.5 and 50.1% decline in serum uric acid levels 
and 8.79 and 21.9% decline in serum creatinine levels were 
observed on day10 and 30, respectively in the aqueous fraction of I. 
batatas treated group. Metformin treatment lowered serum urea 
level by 7.36 and 21.4%, uric acid level by 14.4 and 40.7% and 
serum creatinine level by 9.90 and 31.1% on day10 and 30, 
respectively.
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Table 6: Effect of aqueous fraction of aqueous extract of I. batatas leaves and standard drug, metformin, on liver and kidney function 
markers of STZ-induced diabetic rats 
Group  
Day 
Biochemical Parameters (Serum) 
Liver Function Markers Renal Function Markers 






Normal Control (1.0% Gum acacia) 0 11.4±1.08 13.6±1.19 21.0±1.69 2.04±0.18 0.37±0.02 
10 12.8±0.61 13.9±1.13 23.2±1.14 2.05±0.17 0.39±0.05 
20 12.8±0.60 14.1±1.08 24.2±1.01 2.05±0.28 0.39±0.02 
30 13.7±0.76 14.5±1.13 24.5±0.88 2.08±0.19 0.40±0.2 
Sham treated Control 
(1.0% Gum acacia) 
0 82.0±4.07 88.3±3.20 85.5±2.41 8.42±0.72 0.83±0.04 
10 81.8±2.54 89.0±2.82 86.2±1.96 8.55±0.73 0.83±0.04 
20 84.0±2.49 89.2±2.73 88.0±2.29 8.59±0.67 0.86±0.05 
30 86.7±1.86 89.2±2.73 88.2±2.12 8.66±0.68 0.86±0.03 
Aqueous fraction of aqueous extract of I. 
batatas leaves treated 
(100 mg/kg p. o) 































(100 mg/kg p. o) 






























 Values are mean±SE. of six rats. p*<0.05, p**<0.01, ns: not significant 
 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
and metformin on fasting blood glucose and OGTT of neonatally 
STZ induced diabetic rats  
Table 7 depicts the effect of an aqueous fraction of aqueous extract 
of I. batatas leaves and metformin on fasting blood glucose and oral 
glucose tolerance of post glucose loaded neonatally STZ-induced 
diabetic rats. Mentally STZ-induced diabetic rats showed abnormal 
glucose tolerance after 12 weeks compared to sham treated control 
(table 7). The aqueous fraction of aqueous extract of I. batatas leaves 
caused a decline in fasting blood glucose level and improved oral 
glucose tolerance of neonatally STZ-induced diabetic rats start from 
7 days, which continued up to the termination of experiment i.e. on 
day 28 as shown in table 7. The treatment of aqueous fraction of I. 
batatas leaves and metformin at the doses of 100 mg/kg b.w. to 
these diabetic rats caused significant improvement on their glucose 
intolerance.  
The aqueous fraction of I. batatas leaves treatment improved their 
OGTT around 22.6% (p<0.01) and 51.8% (p<0.01) on 14 and 28 
days, respectively. Whereas, metformin improved the OGTT around 
30.5% (p<0.01) and 59.2% (p<0.01) on day 14 and 28, respectively.
 
Table 7: Effect of aqueous fraction of aqueous extract of I. batatas leaves and standard drug, metformin on fasting blood glucose, 
improvement in OGTT of neonatally STZ treated diabetic rats 
Group  Fasting blood glucose (mg/dl) Oral Glucose tolerance (0-120 min) (AUC±SEM) 




















































































Metfor 191.7±1 164.0±2. 129.5±3. 104.7±2. 107.2±1.81 46830±84 36900±60 33080±19 23280±665 21200±768
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.6 (50.8)** .7 (59.2)** 
Values are mean±SE. of six rats. p*<0.05, p**<0.01, ns: not significant  
 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
and metformin on serum insulin level of neonatally STZ treated 
diabetic rats  
Fig. 5 represents the effect of an aqueous fraction of aqueous extract 
of I. batatas leaves and metformin on serum insulin levels of 
neonatally STZ-induced diabetic rats at the doses of 100 mg/kg b.w. 
In the aqueous fraction of I. batatas leaves and metformin treated 
groups, the serum insulin levels were increased by 47.4% and 
29.2%, respectively on day 30 post treatment. 
 
 
Fig. 5: Effect of aqueous fraction (aqu frac) of aqueous extract of 
I. batatas (I. b) leaves and standard drug, metformin on serum 
insulin profile of neonatally STZ induced diabetic rats. 
Statistical significance p**<0.01 compared to sham control 
 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
on the 2-DG uptake 
Fig.6 represents the effect of an aqueous fraction of aqueous extract 
of I. batatas leaves on glucose uptake in L6 cells. Aqueous fraction of 
I. batatas leaves were evaluated for glucose uptake assay using 2-
deoxyglucose (2-DOG) in L6 cells, increased basal glucose uptake in 
a concentration dependent manner in L6 cells.  
Aqueous fraction of I. batatas leaves increased basal glucose uptake 
in L6 myotubes to a significant level at a minimum concentration of 
10 μg/ml (1.37-fold, p<0.05). Maximum stimulation was observed at 
20 μg/ml concentration (1.61-fold, p<0.05). Pre-incubation of 
myotubes with metformin for 16 h at a 500 μM concentration 
increases the glucose uptake 1.78-fold (p<0.01). 
 
 
Fig. 6: Effect of aqueous fraction of I. batatas leaves and 
standard drug, metformin at 500 μM concentration on 2-
deoxyglucose uptake by differentiated myotubes (L-6). Results 
are expressed as fold change over control. Values are mean±S. 
E. of three independent experiments; p values **<0.01, 
***<0.001 relative to control 
Effect of aqueous fraction of aqueous extract of I. batatas leaves 
on α-glucosidase enzyme 
Fig. 7 shows the inhibition on α-glucosidase by an aqueous fraction of 
I. batatas leaves and acarbose. The aqueous fraction of I. batatas leaves 
exerted an inhibitory effect on a α-glucosidase by showing around 
62.9% inhibition at the concentration of 100 μg/ml compared the 
acarbose which showed around 66.2% inhibition on α-glucosidase at 
100 μg/ml. The aqueous fraction of I. batatas leaves caused 50% 
inhibition (IC50=53.0 μg/ml). Whereas, the standard drug, an acarbose 
showed 50% inhibition at (IC50
 
=43.6 μg/ml) (fig.7).  
 
Fig. 7: In vitro inhibition of α-glucosidase enzyme by the 
aqueous fraction of I. batatas leaves. IC50
 
=Values are means±SE 
of three replicates 
Effect of aqueous fraction of aqueous extract of I. batatas leaves, 
on aldose reductase (AR) activity from the eye lenses of both 
normal rats and STZ-induced diabetic rats  
The specific activities of AR in normal and streptozotocin-induced 
diabetic rats were calculated to be around 0.0823 and 0.1493 
µmol/min/mg protein, respectively. Quercetin, a standard inhibitor, 
showed 50% inhibition (IC50) on aldose reductase at 6.04μg/ml 
(20μM) in normal rat eye lens and at 0.69 μg/ml (2.1 μM) in diabetic 
rat eye lens. The aqueous fraction of I. batatas leaves showed 
significant 50% inhibition on aldose reductase from the dose 
response curve at 3.31 µg/ml in normoglycemic rats and IC50
DISCUSSION 
 for 
aldose reductase activity from eye lens of diabetic rats at 5.81 μg/ml 
as shown in fig. 8A & 8B. 
Ipomoea batatas L. (Sweet Potato), has been recognized as a folk 
medicine for the treatments of diabetes and other metabolic 
diseases [19, 20]. Lako et al., [21] results, showed that sweet potato 
leaves have high contents of total phenolics and flavonoids that 
could have profound benefits for combating chronic degenerative 
disorders [22, 23]. White-skinned sweet potato has been known to 
exhibit antihyperglycemic activity in normal rats and diabetic rats 
[8, 9, 20]. It has been shown that the active ingredients of white-
skinned sweet potato, presumably an acidic glycoprotein [9], 
prevents and improves the symptoms of diabetes and hypoglycemia 
as well as, stimulate the immune response [24]. Liao et al., [25] 
study demonstrated that the water extract of sweet potato leaves 
has strong antioxidant activity.  
In the present study, ethanolic, ethanolic: aqueous and aqueous 
extracts of I. batatas leaves were evaluated for their 
antihyperglycemic effect on sucrose loaded normal rats and STZ-
induced diabetic rats. Of all these extracts, the aqueous extract of I. 
batatas leaves showed most significant improvement in the blood 
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glucose profile of post sucrose loaded normal rats and STZ-induced 
diabetic rats compared to that of standard antidiabetic drugs, 
glybenclamide and metformin, respectively, indicating the insulin 
mimetic, insulin secretaceous or insulin sensitizing effect of aqueous 
extract of leaves of I. batatas for glucose utilization by peripheral 
tissues on postprandial rise hyperglycemia in sucrose loaded normal 
and STZ-induced diabetic rats or attributed to inhibition of the 
intestinal α-glucosidase enzymatic action of the breakdown of 
polysaccharide sugars in its monomeric form and thus inhibiting the 
postprandial increase of plasma blood glucose. 
 
 
Fig. 8: In vitro inhibition of aldose reductase by the aqueous fraction of I. batatas leaves (A) Normal eye lens (B) Diabetic eye lens. 
IC50
 
=Values are means±SE of three replicates 
Further, the isolated fractions, from the aqueous extract of I. batatas 
leaves were evaluated for their antihyperglycemic effect on STZ-
induced diabetic rats. Of these fractions, the aqueous fraction of the 
leaves of I. batatas showed most significant decline in fasting blood 
glucose level of STZ-induced diabetic rats. However, antidiabetic 
efficacy and hypoglycemic mechanisms of aqueous fraction of 
aqueous extract of I. batatas leaves are not fully defined in different 
diabetic models. Therefore, in the present study, antihyperglycemic 
and anti-dyslipidemic activities of the aqueous fraction of I. batatas 
leaves were identified in validated animal models of type 2 diabetes 
mellitus i.e. STZ-induced diabetic rats; and 2-days neonates (n) 2-
STZ-induced diabetic rats.  
STZ has been used to induce diabetes in animals in the present study 
as, STZ injection selectively destroys pancreatic β-cells and leads to 
hyperglycemia, markedly declining the level of serum insulin and its 
biosynthesis and produces diabetes in STZ treated rats [26]. The 
persistent hyperglycemia is responsible for the development of 
diabetic complications like dysfunction, and failure of different 
organs, especially the eyes, renal and blood vessels. The STZ induced 
model is the confirmatory model for the screening of antidiabetic 
agents for diabetes mellitus. The glycosylated haemoglobin increase 
in the state of persistent hyperglycemia, positively correlate with the 
concentration of glucose in the blood [27, 28].  
In the present study, STZ induced diabetic rats when treated with an 
aqueous fraction of aqueous extract of I. batatas leaves and 
metformin showed significant reduction in the HbA1c level on day 
30post treatment, however, significantly no gain in body weight was 
observed. In accordance with the results of Rasineni et al., [29] 
similar diabetic features such as polyphagia, polydipsia, and 
polyuria, loss of body weight, hypo insulinemia, hyperglycemia and 
hyperlipidemia were observed in the STZ-induced diabetic rats in 
the present study. Despite of high food intake, a reduction in the 
body weight of diabetic rats was reasonable because of excessive 
catabolism of fats and protein [28, 29]. It has been shown that both 
alloxan and STZ-induced diabetic rats have insulin deficiency, 
responsible for the accumulation of lipids [30].  
It is evident from the present study that the treatment with the 
aqueous fraction of I. batatas leaves significantly improved the oral 
glucose tolerance, increases the insulin production and decreases 
the serum level of TG, TC and LDL-C, while increases the serum level 
of HDL-C in STZ-induced diabetic rats, an insulin increase might lead 
to activation of the enzyme lipoprotein lipase which further lowers 
the serum triglyceride level. These results are in accordance with 
previous studies on the white skinned tuber roots of sweet potato (I. 
batatas), declined the blood glucose level in STZ-induced type 2 
diabetic rats by inducing pancreatic β-cells regeneration, increasing 
insulin expression, secretion and re-granulation of pancreatic islet 
beta cells, improvement in β-cells mass [6, 7, 9, 20].  
The chronic hyperglycemia also induces the elevation of serum 
levels of of ALT, AST, and urea, uric acid and creatinine, which are 
considered as the significant markers of liver and renal dysfunctions 
[31-33]. The oral administration of the aqueous fraction of I. batatas 
leaves to STZ-induced diabetic rats for 30 days improved the liver 
and renal functions as evidenced in the present study by significant 
(p<0.01) decreased in the serum level of ALT, AST, and urea, uric 
acid, and creatinine, thus indicating the hepatoprotective and 
renoprotective activity exhibited by the aqueous fraction of I. 
batatas leaves.  
The neonatal-STZ treated rats are suitable model of type 2 diabetes 
as it has the potential advantage over others by exhibiting the 
various stages of type 2 diabetes mellitus such as impaired glucose 
tolerance, mild, moderate and severe hyperglycemia with alteration 
of dose and days of STZ injection. It has been shown in the previous 
studies that neonatally STZ-induced diabetic rats exhibits lowered 
plasma insulin level, increased glucose levels and reduction in 
pancreatic insulin content [34]. The neonatally STZ-induced diabetic 
rats are considered to be better tools for the elucidation of the 
mechanisms associated with regeneration of the beta cells, the 
functional exhaustion of the beta cells and the emergence of defects 
in insulin action [35, 36]. A single injection of STZ at the dose range 
of 80-100 mg/kg of STZ to one or two or five days old Sprague-
Dawley neonatal rats has been reported to produce type 2 diabetic 
conditions [35, 37]. The results of the present study indicate that 
neonatally STZ induced diabetic rats develop moderate type 2 
diabetes when compared with normal rats, however, the animals 
showed gradual improvement in oral glucose tolerance and serum 
insulin level on treatment with the aqueous fraction of I. batatas 
leaves in comparison to the control group as shown in table 7 and 
fig. 5.  
The α-glucosidase are found on the surface of brush border of small 
intestinal cells, which catalyzes carbohydrates into oligosaccharide 
units and α-glucosidases inhibitors inhibit maltase, sucrose and 
other disaccharide hydrolases (i.e., represses the degradation of 
disaccharides, oligosaccharides, and polysaccharides into 
monosaccharides) in the brush border membrane of the small 
intestine [38, 39]. In the present study, the aqueous fraction of 
aqueous extract of I. batatas leaves showed marked in vitro 
inhibition of α-glucosidase enzyme, it indicates the potential enzyme 
inhibiting constituents present in the aqueous fraction of I. batatas 
leaves. Drugs that diminish the postprandial hyperglycemia by 
repressing the absorption of starches are shown to be efficient for 
prevention and management of type 2 diabetes [39]. Several natural 
existing flavonoids possess hypoglycemic potential and have been 
depicted as α-glucosidase inhibitors; they have been considered as a 
promising source for drug development and have also demonstrated 
their marked biological effects in both in vitro and in vivo system 
[40]. AR is the first enzyme in the polyol pathway, which catalyzes 
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the reduction of glucose to the corresponding sugar alcohol, sorbitol 
utilizing NADPH as a cofactor, which is subsequently metabolized to 
fructose by sorbitol dehydrogenase [41, 42]. Sorbitol accumulation 
leads to osmotic swelling, membrane permeability changes and 
oxidative stress, which finally cause cellular injury [42, 43]. Many 
studies with experimental animals suggest that inhibition of aldose 
reductase could be effective in the prevention of some diabetic 
complications, including cataract, retinopathy, nephropathy and 
neuropathy [44]. In the present study the aqueous fraction of I. 
batatas leaves also showed in vitro inhibition of aldose reductase 
(AR) activity in a dose-dependent manner. It is evident from the 
results shown in fig. 7 and fig. 8 that the aqueous fractions of 
aqueous extract of I. batatas leaves possess both an α-glucosidase, 
and aldose reductase inhibitory activities along with antidiabetic 
properties, is a good finding in the field of treatment of diabetes 
mellitus.  
L6 muscle cell lines have been considered as a suitable in vitro 
model to study the glucose transport activity [45], since skeletal 
muscles are the major site for primary glucose disposal and glucose 
utilization [46, 47]. It was found in the present study that the 
aqueous fraction of I. batatas leaves significantly enhances the basal 
glucose uptake in a concentration dependent manner, with most 
significant stimulation in glucose uptake at the concentration of 20 
µg/ml showed in L6 skeletal muscle cells. Thus, the in vitro glucose 
uptake activity displayed in L6 cells indicate the antihyperglycemic 
effect exhibited by the aqueous fraction of I. batatas leaves.  
In the present study the antihyperglycemic and antidyslipidemic 
effects have been shown to be exhibited by the aqueous fraction of 
the leaves of Ipomoea batatas. The studies in the literature, are 
available which have demonstrated that the leaf extract of Ipomoea 
batatas contains phytochemicals like alkaloids and flavonoids like 
anthocyanins, saponins which are known to posses’ potent 
antidiabetic and hypolipidemic properties [48, 49]. Anthocyanins 
are natural water-soluble pigments and impart colors in fruits, 
leaves, and flowers of plants. Hence, the antidiabetic effect of the 
aqueous fraction of the leaf extract of Ipomoea batatas might be due 
to the high level of occurrence of anthocyanins, which mediate the 
lowering of blood glucose level and improvement in TG cholesterol 
in serum in type 2 diabetic models used in the study. 
In conclusion, the aqueous fraction of I. batatas leaves have definite 
antihyperglycemic, antidyslipidemic, α-glucosidase, and aldose 
reductase inhibiting activities; it also demonstrates improvement in 
insulin secretion and increase the sensitivity of the insulin 
dependent tissues, i.e. the liver, and muscle tissues resulting in 
glucose utilization. Thus, the present study advocates the 
permissibility of isolation, identifying the active compounds and 
synthesis of plant based antidiabetic agents. 
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